stars 1 stars 2 stars 3

Kymos is a CRO that provides development services for pharmaceutical, biotechnology, veterinary, fine chemistry, cosmetics and nutraceuticals industries. The main areas of activity are the following ones: i) Immunogenicity studies and immunoassay of innovative biological drugs, biosimilars and vaccines. ii) Bioanalysis in preclinical and clinical studies, including full bioequivalence studies. iii) Quality control, stability studies and analytical development of drug substances and drug products (physico-chemical and microbiological testing) iv) Process analytical technology services, using NIR and RAMAN and QbD strategies. Kymos is certified in GLP's and GMP's compliance and it has been authorized as partial manufacturer in quality control.

Kymos Questions

The Kymos annual revenue was $29.6 million in 2026.

Angel Martínez Punzano is the CFO of Kymos.

183 people are employed at Kymos.

The NAICS codes for Kymos are [32541, 325, 3254, 32].

The SIC codes for Kymos are [283, 28].

Top Kymos Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users